CircRNAs: Emerging Bladder Cancer Biomarkers and Targets

Zhaofeng Liang1, Wenhao Guo1, Shikun Fang1

  • 1Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.

Frontiers in Oncology
|January 25, 2021
PubMed

Insights

Circular RNAs (circRNAs) show promise as biomarkers for bladder cancer (BC) due to their stability and specific expression. Research highlights their roles in BC development and potential for diagnosis and treatment.

Area of Science:

  • Molecular Biology
  • Genomics
  • Oncology

Background:

  • Circular RNAs (circRNAs) are covalently closed RNA molecules with unique stability and diverse functions.
  • Aberrant expression of circRNAs is linked to various diseases, including bladder cancer (BC).

Purpose of the Study:

  • To summarize the biogenesis, functions, and roles of circRNAs in bladder cancer.
  • To review the current research progress on circRNAs in BC.
  • To focus on the potential application of circRNAs as biomarkers for BC diagnosis, treatment, and prognosis.

Main Methods:

  • High-throughput sequencing technology
  • Bioinformatics analysis
  • Literature review

Main Results:

  • CircRNAs possess characteristics like high abundance, stability, and tissue specificity, making them suitable biomarkers.
  • CircRNAs function as regulators of gene transcription, miRNA sponges, and protein interactors.
  • Some circRNAs have been identified to encode proteins.

Conclusions:

  • CircRNAs hold significant potential as diagnostic, therapeutic, and prognostic biomarkers for bladder cancer.
  • Further research into circRNAs could lead to novel strategies for BC management.